0

Close
 
Upcoming Allied Market Research
2023
Intrapartum Devices Market

Intrapartum Devices Market

by Product Type (Monitors, Electrodes), by Method (Invasive, Non-Invasive) and by End User   (Hospitals, Clinics, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Medical Devices & Supplies
Report Code: A13325
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Intrapartum Devices Market

Request Now !

Intrapartum devices are the most commonly used methods for monitoring the fetus during labor. An intrapartum device is used to monitor uterus activity and heart rate of the fetus. This device helps to reduce the complication of fetus such as brain damage, cerebral palsy, and newborn seizures which results in death during childbirth. Intrapartum devices include electrodes and monitors that are used to monitor the fetus. Moreover, they are used to detect high blood pressure, bleeding, and other side effects.

COVID-19 Impact Analysis

COVID-19 is an infectious disease that first emerged in late December in Hubei province of the Wuhan city in China. The virus that causes, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is highly infectious and is transmitted from person to person. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a pandemic on March 11, 2020.

There is an increase in the demand for medical supplies needed for the infected population. Respiratory support devices such as atomizers, life support machines, oxygen generators, and monitors are among the primarily used medical devices in primary clinical treatment. Moreover, COVID-19 has also resulted in the significant increase in the in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. The need for medical supplies has increased among both from the healthcare professionals and the civil population for precautionary measures, owing to rise in number of COVID-19 cases worldwide. Manufacturers of these products have an opportunity to profit from this increased demand for medical supplies to ensure appropriate and consistent supply of personal protective equipment in the market. Therefore, COVID 19 is expected to have a significant impact on the intrapartum device market.

Top Impacting Factors

  • Increase in the demand for maternal and fetal care devices, surge in the use of fetal monitors in hospitals and clinics, rise in birth rates, increase in cost- effective treatment, and surge in the number of preterm births drive the growth of the intrapartum device market.
  • Furthermore, improvement in maternity care centers, development of healthcare infrastructure and advanced medical devices in the healthcare facilities, launch of new technologically advanced products, government initiatives to raise awareness about preterm births, and strategic initiatives such as mergers and partnerships with local players boost the growth of the intrapartum device market.
  • However, the issues such as high cost of the treatment and low awareness regarding use of intrapartum devices hinder the growth of the intrapartum device market.
  • Contrarily, increase in investment in the healthcare sector by emerging countries as well as focus on developing advance intrapartum devices are expected to offer lucrative opportunities for the expansion of the market.

Market Trend

New Product Launches to Flourish the Market

Philips launched an obstetrics monitoring device named Avalon CL in 2020. This device is based on wireless technology and can help medical professionals to monitor fetal development in the condition of COVID-19 from their homes.

Analogic Corporation announced the launch of its new bkSpecto Ultrasound stage for urology in May 2018. This product exhibits superior imaging capabilities and offers real -time monitoring guidance. This product can be used for pregnancy diagnosis & monitoring as well.

Key Benefits of the Report

  • This study presents the analytical depiction of intrapartum device market industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the market share.
  • The current market is quantitatively analyzed to highlight the growth scenario of the market intrapartum device market.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed market analysis depending on competitive intensity and the competition that will take shape in coming years.

Questions Answered in the Intrapartum Device Market Report                  

  • Who are the leading market players active in the intrapartum device market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What are the future projections that would help in taking further strategic steps?
  • What is "intrapartum device"?
  • What is the prediction of the "intrapartum device" market in the future?
  • Who are the leading global players in the "intrapartum device" market?
  • What are the current and predicted trends?
  • What are the key benefits of the "intrapartum device" market report?

 Intrapartum Devices Market Report Highlights

Aspects Details
By Product Type
  • Monitors
  • Electrodes
    • Fetal Scalp Electrodes
    • Intrauterine Pressure Catheters
    • Transducers For Fetal Heart Rate
    • Transducers For Uterine Contractions
By Method
  • Invasive
  • Non-Invasive
By End User  
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Cooper Companies, Inc., Analogic Corporation, Stryker Corporation, Cardinal Health, Medtronic PLC, GE Healthcare, Huntleigh Healthcare Limited, MindChild Medical, Koninklijke Philips N.V., Olympus Corporation
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: INTRAPARTUM DEVICES MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. Monitors

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Electrodes

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

      • 4.3.4. Fetal Scalp Electrodes

        • 4.3.4.1. Market Size and Forecast

      • 4.3.4. Intrauterine Pressure Catheters

        • 4.3.4.1. Market Size and Forecast

      • 4.3.4. Transducers For Fetal Heart Rate

        • 4.3.4.1. Market Size and Forecast

      • 4.3.4. Transducers For Uterine Contractions

        • 4.3.4.1. Market Size and Forecast

  • CHAPTER 5: INTRAPARTUM DEVICES MARKET, BY METHOD

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Method

    • 5.2. Invasive

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Non-Invasive

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: INTRAPARTUM DEVICES MARKET, BY END USER  

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User  

    • 6.2. Hospitals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Clinics

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Ambulatory Surgical Centers

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Others

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

  • CHAPTER 7: INTRAPARTUM DEVICES MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product Type

      • 7.2.3. Market Size and Forecast, By Method

      • 7.2.4. Market Size and Forecast, By End User  

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Intrapartum Devices Market

        • 7.2.6.1. Market Size and Forecast, By Product Type
        • 7.2.6.2. Market Size and Forecast, By Method
        • 7.2.6.3. Market Size and Forecast, By End User  

      • 7.2.7. Canada Intrapartum Devices Market

        • 7.2.7.1. Market Size and Forecast, By Product Type
        • 7.2.7.2. Market Size and Forecast, By Method
        • 7.2.7.3. Market Size and Forecast, By End User  

      • 7.2.8. Mexico Intrapartum Devices Market

        • 7.2.8.1. Market Size and Forecast, By Product Type
        • 7.2.8.2. Market Size and Forecast, By Method
        • 7.2.8.3. Market Size and Forecast, By End User  

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product Type

      • 7.3.3. Market Size and Forecast, By Method

      • 7.3.4. Market Size and Forecast, By End User  

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Intrapartum Devices Market

        • 7.3.6.1. Market Size and Forecast, By Product Type
        • 7.3.6.2. Market Size and Forecast, By Method
        • 7.3.6.3. Market Size and Forecast, By End User  

      • 7.3.7. Germany Intrapartum Devices Market

        • 7.3.7.1. Market Size and Forecast, By Product Type
        • 7.3.7.2. Market Size and Forecast, By Method
        • 7.3.7.3. Market Size and Forecast, By End User  

      • 7.3.8. Italy Intrapartum Devices Market

        • 7.3.8.1. Market Size and Forecast, By Product Type
        • 7.3.8.2. Market Size and Forecast, By Method
        • 7.3.8.3. Market Size and Forecast, By End User  

      • 7.3.9. Spain Intrapartum Devices Market

        • 7.3.9.1. Market Size and Forecast, By Product Type
        • 7.3.9.2. Market Size and Forecast, By Method
        • 7.3.9.3. Market Size and Forecast, By End User  

      • 7.3.10. UK Intrapartum Devices Market

        • 7.3.10.1. Market Size and Forecast, By Product Type
        • 7.3.10.2. Market Size and Forecast, By Method
        • 7.3.10.3. Market Size and Forecast, By End User  

      • 7.3.11. Russia Intrapartum Devices Market

        • 7.3.11.1. Market Size and Forecast, By Product Type
        • 7.3.11.2. Market Size and Forecast, By Method
        • 7.3.11.3. Market Size and Forecast, By End User  

      • 7.3.12. Rest Of Europe Intrapartum Devices Market

        • 7.3.12.1. Market Size and Forecast, By Product Type
        • 7.3.12.2. Market Size and Forecast, By Method
        • 7.3.12.3. Market Size and Forecast, By End User  

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product Type

      • 7.4.3. Market Size and Forecast, By Method

      • 7.4.4. Market Size and Forecast, By End User  

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Intrapartum Devices Market

        • 7.4.6.1. Market Size and Forecast, By Product Type
        • 7.4.6.2. Market Size and Forecast, By Method
        • 7.4.6.3. Market Size and Forecast, By End User  

      • 7.4.7. Japan Intrapartum Devices Market

        • 7.4.7.1. Market Size and Forecast, By Product Type
        • 7.4.7.2. Market Size and Forecast, By Method
        • 7.4.7.3. Market Size and Forecast, By End User  

      • 7.4.8. India Intrapartum Devices Market

        • 7.4.8.1. Market Size and Forecast, By Product Type
        • 7.4.8.2. Market Size and Forecast, By Method
        • 7.4.8.3. Market Size and Forecast, By End User  

      • 7.4.9. South Korea Intrapartum Devices Market

        • 7.4.9.1. Market Size and Forecast, By Product Type
        • 7.4.9.2. Market Size and Forecast, By Method
        • 7.4.9.3. Market Size and Forecast, By End User  

      • 7.4.10. Australia Intrapartum Devices Market

        • 7.4.10.1. Market Size and Forecast, By Product Type
        • 7.4.10.2. Market Size and Forecast, By Method
        • 7.4.10.3. Market Size and Forecast, By End User  

      • 7.4.11. Thailand Intrapartum Devices Market

        • 7.4.11.1. Market Size and Forecast, By Product Type
        • 7.4.11.2. Market Size and Forecast, By Method
        • 7.4.11.3. Market Size and Forecast, By End User  

      • 7.4.12. Malaysia Intrapartum Devices Market

        • 7.4.12.1. Market Size and Forecast, By Product Type
        • 7.4.12.2. Market Size and Forecast, By Method
        • 7.4.12.3. Market Size and Forecast, By End User  

      • 7.4.13. Indonesia Intrapartum Devices Market

        • 7.4.13.1. Market Size and Forecast, By Product Type
        • 7.4.13.2. Market Size and Forecast, By Method
        • 7.4.13.3. Market Size and Forecast, By End User  

      • 7.4.14. Rest of Asia Pacific Intrapartum Devices Market

        • 7.4.14.1. Market Size and Forecast, By Product Type
        • 7.4.14.2. Market Size and Forecast, By Method
        • 7.4.14.3. Market Size and Forecast, By End User  

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product Type

      • 7.5.3. Market Size and Forecast, By Method

      • 7.5.4. Market Size and Forecast, By End User  

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Intrapartum Devices Market

        • 7.5.6.1. Market Size and Forecast, By Product Type
        • 7.5.6.2. Market Size and Forecast, By Method
        • 7.5.6.3. Market Size and Forecast, By End User  

      • 7.5.7. South Africa Intrapartum Devices Market

        • 7.5.7.1. Market Size and Forecast, By Product Type
        • 7.5.7.2. Market Size and Forecast, By Method
        • 7.5.7.3. Market Size and Forecast, By End User  

      • 7.5.8. Saudi Arabia Intrapartum Devices Market

        • 7.5.8.1. Market Size and Forecast, By Product Type
        • 7.5.8.2. Market Size and Forecast, By Method
        • 7.5.8.3. Market Size and Forecast, By End User  

      • 7.5.9. UAE Intrapartum Devices Market

        • 7.5.9.1. Market Size and Forecast, By Product Type
        • 7.5.9.2. Market Size and Forecast, By Method
        • 7.5.9.3. Market Size and Forecast, By End User  

      • 7.5.10. Argentina Intrapartum Devices Market

        • 7.5.10.1. Market Size and Forecast, By Product Type
        • 7.5.10.2. Market Size and Forecast, By Method
        • 7.5.10.3. Market Size and Forecast, By End User  

      • 7.5.11. Rest of LAMEA Intrapartum Devices Market

        • 7.5.11.1. Market Size and Forecast, By Product Type
        • 7.5.11.2. Market Size and Forecast, By Method
        • 7.5.11.3. Market Size and Forecast, By End User  

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning,2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Analogic Corporation

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Cardinal Health

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Cooper Companies, Inc.

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. GE Healthcare

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Koninklijke Philips N.V.

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Medtronic PLC

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. MindChild Medical

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Olympus Corporation

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Stryker Corporation

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Huntleigh Healthcare Limited

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL INTRAPARTUM DEVICES MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL INTRAPARTUM DEVICES MARKET FOR MONITORS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL INTRAPARTUM DEVICES MARKET FOR ELECTRODES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL INTRAPARTUM DEVICES MARKET, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL INTRAPARTUM DEVICES MARKET FOR INVASIVE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL INTRAPARTUM DEVICES MARKET FOR NON-INVASIVE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL INTRAPARTUM DEVICES MARKET, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL INTRAPARTUM DEVICES MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL INTRAPARTUM DEVICES MARKET FOR CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL INTRAPARTUM DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL INTRAPARTUM DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL INTRAPARTUM DEVICES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. NORTH AMERICA INTRAPARTUM DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 17. U.S. INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 18. U.S. INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 19. U.S. INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 20. CANADA INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 21. CANADA INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 22. CANADA INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 23. MEXICO INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 24. MEXICO INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 25. MEXICO INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 26. EUROPE INTRAPARTUM DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 27. EUROPE INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 28. EUROPE INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 29. EUROPE INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 30. FRANCE INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 31. FRANCE INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 32. FRANCE INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 33. GERMANY INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 34. GERMANY INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 35. GERMANY INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 36. ITALY INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 37. ITALY INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 38. ITALY INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 39. SPAIN INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 40. SPAIN INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 41. SPAIN INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 42. UK INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 43. UK INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 44. UK INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 45. RUSSIA INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 46. RUSSIA INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 47. RUSSIA INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 48. REST OF EUROPE INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 49. REST OF EUROPE INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 50. REST OF EUROPE INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 51. ASIA-PACIFIC INTRAPARTUM DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 52. ASIA-PACIFIC INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 53. ASIA-PACIFIC INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 54. ASIA-PACIFIC INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 55. CHINA INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 56. CHINA INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 57. CHINA INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 58. JAPAN INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 59. JAPAN INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 60. JAPAN INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 61. INDIA INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 62. INDIA INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 63. INDIA INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 64. SOUTH KOREA INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 65. SOUTH KOREA INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 66. SOUTH KOREA INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 67. AUSTRALIA INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 68. AUSTRALIA INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 69. AUSTRALIA INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 70. THAILAND INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 71. THAILAND INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 72. THAILAND INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 73. MALAYSIA INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 74. MALAYSIA INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 75. MALAYSIA INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 76. INDONESIA INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 77. INDONESIA INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 78. INDONESIA INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 79. REST OF ASIA PACIFIC INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 80. REST OF ASIA PACIFIC INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 81. REST OF ASIA PACIFIC INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 82. LAMEA INTRAPARTUM DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 83. LAMEA INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 84. LAMEA INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 85. LAMEA INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 86. BRAZIL INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 87. BRAZIL INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 88. BRAZIL INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 89. SOUTH AFRICA INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 90. SOUTH AFRICA INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 91. SOUTH AFRICA INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 92. SAUDI ARABIA INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 93. SAUDI ARABIA INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 94. SAUDI ARABIA INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 95. UAE INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 96. UAE INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 97. UAE INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 98. ARGENTINA INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 99. ARGENTINA INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 100. ARGENTINA INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 101. REST OF LAMEA INTRAPARTUM DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 102. REST OF LAMEA INTRAPARTUM DEVICES, BY METHOD, 2022-2032 ($MILLION)
  • TABLE 103. REST OF LAMEA INTRAPARTUM DEVICES, BY END USER  , 2022-2032 ($MILLION)
  • TABLE 104. ANALOGIC CORPORATION: KEY EXECUTIVES
  • TABLE 105. ANALOGIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 106. ANALOGIC CORPORATION: OPERATING SEGMENTS
  • TABLE 107. ANALOGIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 108. ANALOGIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 109. CARDINAL HEALTH: KEY EXECUTIVES
  • TABLE 110. CARDINAL HEALTH: COMPANY SNAPSHOT
  • TABLE 111. CARDINAL HEALTH: OPERATING SEGMENTS
  • TABLE 112. CARDINAL HEALTH: PRODUCT PORTFOLIO
  • TABLE 113. CARDINAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 114. COOPER COMPANIES, INC.: KEY EXECUTIVES
  • TABLE 115. COOPER COMPANIES, INC.: COMPANY SNAPSHOT
  • TABLE 116. COOPER COMPANIES, INC.: OPERATING SEGMENTS
  • TABLE 117. COOPER COMPANIES, INC.: PRODUCT PORTFOLIO
  • TABLE 118. COOPER COMPANIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 119. GE HEALTHCARE: KEY EXECUTIVES
  • TABLE 120. GE HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 121. GE HEALTHCARE: OPERATING SEGMENTS
  • TABLE 122. GE HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 123. GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 124. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
  • TABLE 125. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • TABLE 126. KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
  • TABLE 127. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
  • TABLE 128. KONINKLIJKE PHILIPS N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 129. MEDTRONIC PLC: KEY EXECUTIVES
  • TABLE 130. MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 131. MEDTRONIC PLC: OPERATING SEGMENTS
  • TABLE 132. MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 133. MEDTRONIC PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 134. MINDCHILD MEDICAL: KEY EXECUTIVES
  • TABLE 135. MINDCHILD MEDICAL: COMPANY SNAPSHOT
  • TABLE 136. MINDCHILD MEDICAL: OPERATING SEGMENTS
  • TABLE 137. MINDCHILD MEDICAL: PRODUCT PORTFOLIO
  • TABLE 138. MINDCHILD MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 139. OLYMPUS CORPORATION: KEY EXECUTIVES
  • TABLE 140. OLYMPUS CORPORATION: COMPANY SNAPSHOT
  • TABLE 141. OLYMPUS CORPORATION: OPERATING SEGMENTS
  • TABLE 142. OLYMPUS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 143. OLYMPUS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 144. STRYKER CORPORATION: KEY EXECUTIVES
  • TABLE 145. STRYKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 146. STRYKER CORPORATION: OPERATING SEGMENTS
  • TABLE 147. STRYKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 148. STRYKER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 149. HUNTLEIGH HEALTHCARE LIMITED: KEY EXECUTIVES
  • TABLE 150. HUNTLEIGH HEALTHCARE LIMITED: COMPANY SNAPSHOT
  • TABLE 151. HUNTLEIGH HEALTHCARE LIMITED: OPERATING SEGMENTS
  • TABLE 152. HUNTLEIGH HEALTHCARE LIMITED: PRODUCT PORTFOLIO
  • TABLE 153. HUNTLEIGH HEALTHCARE LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAPARTUM DEVICES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL INTRAPARTUM DEVICES MARKET
  • FIGURE 3. SEGMENTATION INTRAPARTUM DEVICES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN INTRAPARTUM DEVICES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALINTRAPARTUM DEVICES MARKET
  • FIGURE 11. INTRAPARTUM DEVICES MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 12. INTRAPARTUM DEVICES MARKET FOR MONITORS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. INTRAPARTUM DEVICES MARKET FOR ELECTRODES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. INTRAPARTUM DEVICES MARKET SEGMENTATION, BY BY METHOD
  • FIGURE 15. INTRAPARTUM DEVICES MARKET FOR INVASIVE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. INTRAPARTUM DEVICES MARKET FOR NON-INVASIVE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. INTRAPARTUM DEVICES MARKET SEGMENTATION, BY BY END USER  
  • FIGURE 18. INTRAPARTUM DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. INTRAPARTUM DEVICES MARKET FOR CLINICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. INTRAPARTUM DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. INTRAPARTUM DEVICES MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 23. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 24. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 25. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 26. COMPETITIVE DASHBOARD
  • FIGURE 27. COMPETITIVE HEATMAP: INTRAPARTUM DEVICES MARKET
  • FIGURE 28. Top player positioning, 2022
  • FIGURE 29. ANALOGIC CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 30. ANALOGIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 31. ANALOGIC CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 32. CARDINAL HEALTH: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 33. CARDINAL HEALTH: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 34. CARDINAL HEALTH: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 35. COOPER COMPANIES, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 36. COOPER COMPANIES, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 37. COOPER COMPANIES, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 38. GE HEALTHCARE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 39. GE HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 40. GE HEALTHCARE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 41. KONINKLIJKE PHILIPS N.V.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 42. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 43. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 44. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 45. MEDTRONIC PLC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 46. MEDTRONIC PLC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 47. MINDCHILD MEDICAL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 48. MINDCHILD MEDICAL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 49. MINDCHILD MEDICAL: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 50. OLYMPUS CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 51. OLYMPUS CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 52. OLYMPUS CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 53. STRYKER CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 54. STRYKER CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 55. STRYKER CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 56. HUNTLEIGH HEALTHCARE LIMITED: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 57. HUNTLEIGH HEALTHCARE LIMITED: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 58. HUNTLEIGH HEALTHCARE LIMITED: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
RELATED TAGS

Purchase Full Report of
Intrapartum Devices Market

Start reading.
This Report and over 66,944+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers